MSD's oral HIF-2 alpha inhibitor Welireg has a third FDA approval, becoming the first oral treatment for a rare form of solid tumour that affects around 2,000 people in the US each year. The green ...

Merck Sharp & Dohme (MSD) has agreed to acquire Cidara Therapeutics in a transaction valued at approximately $9.2 billion, following encouraging results from the company’s phase 2b trial of its lead ...

MSD's efforts to combine cancer immunotherapy Keytruda with its AstraZeneca-partnered PARP drug Lynparza have so far failed – but at last it can point to a partial win in a phase 3 trial. The new data ...

If you have a circulated $2 bill burning a hole in your pocket, think twice before spending it at some store. The bill itself might be worth a lot more than two dollars — enough to build some serious ...

Abstract: This article presents a novel dual linearly polarized shared-aperture 2-bit programmable metasurface (PMS) with high cross-polarization discrimination (XPD). Two orthogonally placed ...